CEP-1347

CAT: 0804-HY-10412Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-10412Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CEP-1347 is an inhibitor of the JNK/SAPK pathway with neuroprotective effects. CEP-1347 blocks JNK1 activation induced by members of the mixed lineage kinase (MLK) family (MLK3, MLK2, MLK1, dual leucine zipper kinase, and leucine zipper kinase) . As an inhibitor of MDM4, CEP-1347 can more effectively inhibit the growth of glioma cells expressing wild-type p53[1][2][3][4][5][6].
CAS Number
[156177-65-0]
Product Name Alternative
KT7515
UNSPSC
12352005
Target
JNK; MDM-2/p53; Mixed Lineage Kinase
Type
Reference compound
Related Pathways
Apoptosis; MAPK/ERK Pathway
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cep-1347.html
Purity
98.50
Solubility
10 mM in DMSO
Smiles
C[C@]12N3C4=C(C5=CC(CSCC)=CC=C53)C(CNC6=O)=C6C(C7=C8)=C4N([C@@H](C[C@]2(O)C(OC)=O)O1)C7=CC=C8CSCC
Molecular Formula
C33H33N3O5S2
Molecular Weight
615.76
References & Citations
[1]Saporito MS, Hudkins RL, Maroney AC. Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases. Prog Med Chem. 2002;40:23-62. |[2]Mitobe Y, Nakagawa-Saito Y, Togashi K, et al. CEP-1347 Targets MDM4 Protein Expression to Activate p53 and Inhibit the Growth of Glioma Cells. Anticancer Res. 2022;42 (10) :4727-4733. |[3]Mitobe Y, Suzuki S, Nakagawa-Saito Y, et al. The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo. Biomedicines. 2023;11 (7) :1967.|[4]Maroney AC, Finn JP, Connors TJ, et al. Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J Biol Chem. 2001;276 (27) :25302-25308. |[5]Maroney AC, et al. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci. 1998;18 (1) :104-111. |[6]Wagner AC, et al. EP-1347 inhibits caerulein-induced rat pancreatic JNK activation and ameliorates caerulein pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2000;278 (1) :G165-G172.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
JNK1

Related Products

CatalogName
HY-120350-01BI-1347
HY-123172CEP-2563
HY-100946-01CEP-40783
HY-14243CEP-14083
HY-117909-01CEP-40125
HY-16135-01CEP-11981
HY-15343-01CEP-33779
HY-18030CEP-28122
HY-13590CEP-7055
HY-P991435CEP-37248

Alternative Products

CatalogName
TRC-C256695-10MGCEP 1347
M12222-01CEP-1347
A13565-5CEP-1347 5mg
A13565-10CEP-1347 10mg
T200379-01CEP-1347-acid
A13565-1CEP-1347 1mg
A13565-2CEP-1347 2mg
4924/1CEP 1347: 1 mg
M13451-01BI-1347
206156Debio-1347

Popular Products